Search Frequenty Asked Questions

Normal Fonts Larger Fonts Printer Version Email this page Submit Feedback Questions & Answers About CMS Return to cms.hhs.gov Home Normal Fonts Larger Fonts Email this page Submit Feedback Questions & Answers About CMS Return to cms.hhs.gov Home
Return to cms.hhs.gov Home    Return to cms.hhs.gov Home

  


  Professionals   Governments   Consumers   Public Affairs

Medicare Coverage Database

Medicare Coverage home page coverage home | view page help help | view basket basket   
 
tab imageSearchtab imageIndexestab imageReportstab imageDownloadtab image 
    

Search Home > Search Results > View NCA > View Tracking Sheet

NCA Tracking Sheet for Transmyocardial revascularization (TMR) / Percutaneous Myocardial Revascularization (PMR) - MCAC (CAG-00231N)

Issue

The Medicare Coverage Advisory Committee (MCAC) will discuss and make recommendations concerning the quality of the evidence and related issues for the use of transmyocardial revascularization (TMR) and percutaneious myocardial revascularization (PMR) for treatment of severe angina.   TMR is a surgical technique that uses a laser to bore holes through the myocardium of the heart in an attempt to restore perfusion to areas of the heart not being reached due to diseased or clogged arteries; PMR is a subset of this technique which is less invasive and is used as a late or last resort to relieve symptoms of severe angina in patients suffering ischemic heart disease who are not amenable to direct coronary revascularization interventions such as angioplasty, stenting, or open coronary bypass.  Notice of this action is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)).

This tracking sheet does not represent a National Coverage Analysis for TMR or PMR.  It only serves to announce the upcoming MCAC meeting. 

National Coverage Determination(s) 20.6
Benefit Category Inpatient Hospital Services, Physicians' Services
Requestor Name(s) Internally generated
Formal Request Accepted and Review Initiated 6/15/2004
Expected NCA Completion Date N/A
Public Comment Period N/A - 6/30/2004
Lead Analyst(s) JoAnna Baldwin
jbaldwin@cms.hhs.gov
1-410-786-7205
Lead Medical Officer(s) Lori Paserchia, MD
lpaserchia@cms.hhs.gov
1-410-786-2115
Actions Taken
May 30, 2004 Federal Register Notice announcing this MCAC is published. The public meeting will be held on Wednesday, July 14, 2004 from 7:30 a.m. until 3:30 p.m. e.d.t., at the Holiday Inn Inner Harbor, 301 West Lombard Street, Baltimore, MD 21201.
June 15, 2004 Additional information is available including the panel questions, Federal Register Notice and instructions for public commenters. Additional information will be posted closer to the day of the meeting.
June 23, 2004 The technology assessment that will be presented to the panel is now available. Due to the late posting of the assessment, the deadline for receiving public comments has been extended to close of business on June 30, 2004.
June 29, 2004 We have corrected an error in the questions  we posted to our website. We have also defined the term "validity" in the 2nd question.
July 1, 2004 CMS has received a request from the TMR/PMR MCAC panel to add an additional question to address net health benefit. This question is now question #3 . We have extended the deadline to submit a presentation to no later than July 7, 2004.
September 10, 2004 The minutes and transcript  from the July 14, 2004 MCAC meeting are now available for viewing.


new search New Search